Join
Live feed
·
NEWSReleasevia Quantisnow
Kaleido Biosciences Inc. logo

Kaleido Biosciences shares are trading lower on continued momentum after the company announced it intends to voluntarily delist its common stock.

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track KLDO (Kaleido Biosciences Inc.) and more on Quantisnow.